Researchers say that there is a new technology that may allow the rapid injection of drugs that currently require a slow intravenous right.
Patient injections of what is known as antibody drugs, which are usually used to treat cancer, autoimmune diseases and metabolic disorders, need a large amount of fluid, which means the need to undergo an venous distillation that takes a long time, because antibodies, which are proteins, remain only stable in liquids with low concentrations.
The researchers stated in the Journal of Transitional Medicine Sciences that there is a new way to package proteins that allow them to be stored with high concentrations to provide patients using regular syringes or a self -injection device.
And so that the researchers can put proteins in liquid with high concentrations while maintaining their stability and effectiveness, the researchers enveloped small particles with a substance called (Money).
The researchers said that the lunar layer prevents particles from melting or sticking to each other in the liquid and keeping them dry and stable. “We have reached something similar to the chocolate coated with sweets, where the protein is inside and our polymer is a solid glass layer from the outside,” study leader Eric Abel of Stanford University said in a statement.
In the tests conducted using 3 different proteins, the albumin and the human immunosurals and the monochromatic body of the coffee-19 treatment, the researchers managed to inject a solution with more than gay concentration of usual injection fluids.
Abel said that the new method “is likely to work with any biological medication, so that we can easily inject it.”
“This transmits these treatments from an ordeal that takes several hours in the clinic with venous injection to something you can do in seconds using a self -injector in your home,” he added.